Skip to main content

Table 2 Diagnostic investigations in adults

From: Guidelines on the diagnosis and management of the progressive ataxias

Primary care

U&Es

Creatinine

FBC

ESR/CRP

Liver enzymes

γ-GT

TFT

Vitamin B12

Folate

Glucose

CXR

Secondary care (first line)

αFP

Blood film

Caeruloplasmin/copper

Coeliac screen

Creatine kinase

Genetic tests for FRDA, SCA 1, 2, 3, 6, 7 (12, 17) and FXTAS

Lactate

Lipid-adjusted vitamin E and lipoproteins

Lumbar puncture (cells, protein, glucose, cytology, oligoclonal bands, lactate, ferritin)

MRI brain and cervical spine

Anti-Hu/Yo and other paraneoplastic antibodies

Anti-GAD

Anti-VGCC

CT (chest, abdomen, pelvis)

14–3-3 and other proteins in CSF (prion diseases)

Secondary care (second line)

Cholestanol

Plasma oxysterols

Bile acids

Coenzyme Q10(ubiquinone)

Electroencephalography

Very long chain fatty acids

Muscle biopsy

Ophthalmology/OCT

Peripheral nerve conduction studies

Phytanic acid

Remaining genetic tests (NGS)

Total body PET scan

White cell enzymes

  1. U&Es Urea and Electrolytes, FBC Full Blood Count, ESR Erythrocyte Sedimentation Rate, CRP C-Reactive Protein, γ-GT gamma-Glutamyltransferase, TFT Thyroid Function Test, CXR Chest X-ray, αFP alpha-Fetoprotein, GAD Glutamic Acid Decarboxylase, VGCC Voltage-gated Calcium Channel, CT Computerised Tomography, FRDA Friedreich’s Ataxia, SCA Spinocerebellar Ataxia, FXTAS Fragile X Tremor-Ataxia Syndrome, CSF Cerebrospinal Fluid, OCT Optical coherence tomography, NGS Next Generation Sequencing, PET Positron Emission Tomography